Amarin Corp. PLC ADS (AMRN): I agree with you. No way Pfizer is screw...

Followed By	28
Posts	4953
Boards Moderated	0
Alias Born	03/25/2013

mrmainstreet

Tuesday, September 14, 2021 1:16:12 PM

Re: roadkilll post# 354381

I agree with you. No way Pfizer is screwing around in Canada promoting Vascepa without a bigger picture plan in mind IMO.

Of course we're still stuck at $5 and change so clearly not many people in the market are seeing what I'm seeing.

Recent AMRN News

Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 05/24/2022 09:17:45 PM
HLS Therapeutics Obtains Public Reimbursement for Vascepa® in Quebec • PR Newswire (Canada) • 05/24/2022 11:28:00 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/20/2022 11:48:47 AM
Amarin Announces Appointment of New Directors and Board Leadership Changes • GlobeNewswire Inc. • 05/19/2022 12:23:13 PM
Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs • GlobeNewswire Inc. • 05/16/2022 12:00:00 PM
Amarin to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/12/2022 12:00:00 PM
Amarin Nosedives on Disappointing Quarterly Results • TipRanks • 05/05/2022 11:25:49 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/04/2022 11:10:45 AM
Quarterly Report (10-q) • Edgar (US Regulatory) • 05/04/2022 11:07:07 AM
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/04/2022 11:00:00 AM
New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack) • GlobeNewswire Inc. • 05/03/2022 12:00:00 PM
Amended Annual Report (10-k/a) • Edgar (US Regulatory) • 05/02/2022 08:03:25 PM
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl) • GlobeNewswire Inc. • 04/26/2022 12:49:33 PM
Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022 • GlobeNewswire Inc. • 04/19/2022 11:30:00 AM
Analysts’ Top Healthcare Picks: Align Tech (ALGN), Amarin (AMRN) • TipRanks • 04/17/2022 12:36:06 PM
Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes • GlobeNewswire Inc. • 04/01/2022 11:00:00 AM
AOUT, IMRX and AMRN among after hour movers • Seeking Alpha • 03/31/2022 10:13:47 PM
Amarin wins national reimbursement for Vazkepa in Sweden • Seeking Alpha • 03/28/2022 12:45:33 PM
Amarin Receives Reimbursement for VAZKEPA® in Sweden • GlobeNewswire Inc. • 03/28/2022 11:00:00 AM
Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific Session • GlobeNewswire Inc. • 03/21/2022 12:30:00 PM
Amarin recovers amid positive views from Piper Sandler on European strategy • Seeking Alpha • 03/15/2022 07:23:25 PM
Amarin analysis shows Vascepa reduces risk of fatal cardiovascular events • Seeking Alpha • 03/10/2022 02:23:41 PM
Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention • GlobeNewswire Inc. • 03/10/2022 01:47:44 PM
Amarin stock rises after Q4 earnings beat amid Vascepa generic competition • Seeking Alpha • 03/01/2022 12:42:15 PM
Amarin Non-GAAP EPS of $0.06 beats by $0.09, revenue of $144.49M beats by $2.32M • Seeking Alpha • 03/01/2022 11:02:46 AM

More AMRN News

InvestorsHub NewsWire

FEATURED SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment • May 24, 2022 8:36 AM

FEATURED Splash Beverage Group Broadens Reach through Agreement with Maryland's Buck Distributing • May 24, 2022 8:12 AM

Ultrack Systems Fully Acquires California Trucking Company M-Loan Inc. • MJLB • May 24, 2022 9:30 AM

PSYC Teams Up with The Spore Group to Bring Industry-Leading, Psychedelic-Focused Events to Communities Across North America • PSYC • May 24, 2022 8:30 AM

Electromedical Technologies Announces Financial and Operational Highlights for the Three Months Ended March 31, 2022 • EMED • May 24, 2022 6:00 AM

HPIL HOLDING (OTC: HPIL) SETTLES ANOTHER LAWSUIT • HPIL • May 23, 2022 4:30 PM

A.I.S. Resources Identifies Prospective Drill Targets at Reliance Reef and Provides Bright Gold Project Update • AIS • May 20, 2022 8:00 AM

Lomiko Announces Commencement of Exploration Drilling for its La Loutre Graphite Project • LMR • May 19, 2022 10:56 AM

PTOP Announces MOBICARD ™ 2.0 Development Contract has been executed • PTOP • May 19, 2022 10:00 AM

Edison Lithium Spin-Out of Cobalt Assets • EDDYF • May 19, 2022 8:00 AM

Goldshore Resources Announces Innovative Technology Application for Moss Lake Project Exploration and Closing of Non-Brokered Financing • GSHRF • May 19, 2022 8:00 AM

Demand Brands kicks off cultivation at Corralitos Farms • DMAN • May 18, 2022 2:00 PM

Emerging Markets Report: Details, Details • SYTA • May 18, 2022 11:48 AM

American Green, Inc. ™ (OTC:ERBB) Purchases 40,000sq.ft. Cannabis Grow Building for $3,750,000 • ERBB • May 18, 2022 9:25 AM

Green Battery Minerals Completes Resource Expansion Drilling at Zone 1 and Intersects Numerous Holes Ranging from 150 - 200 Feet of Graphite • CZSVF • May 18, 2022 9:19 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

More AMRN News

Detailed Quote